Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
PINC vs DBVT vs ALKS vs OMI
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Medical - Distribution
PINC vs DBVT vs ALKS vs OMI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Biotechnology | Biotechnology | Medical - Distribution |
| Market Cap | $2.34B | $1712.35T | $5.90B | $171M |
| Revenue (TTM) | $1.00B | $0.00 | $1.56B | $2.76B |
| Net Income (TTM) | $-24M | $-168M | $153M | $-1.10B |
| Gross Margin | 72.6% | — | 65.4% | — |
| Operating Margin | -0.0% | — | 12.3% | 1.0% |
| Forward P/E | 20.8x | — | 24.8x | 2.3x |
| Total Debt | $282M | $22M | $70M | $320M |
| Cash & Equiv. | $84M | $194M | $1.12B | $282M |
PINC vs DBVT vs ALKS vs OMI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Nov 25 | Return |
|---|---|---|---|
| Premier, Inc. (PINC) | 100 | 81.2 | -18.8% |
| DBV Technologies S.… (DBVT) | 100 | 30.2 | -69.8% |
| Alkermes plc (ALKS) | 100 | 187.7 | +87.7% |
| Owens & Minor, Inc. (OMI) | 100 | 50.1 | -49.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PINC vs DBVT vs ALKS vs OMI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PINC is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 1 yrs, beta 0.07, yield 3.0%
- -4.6% 10Y total return vs ALKS's -11.0%
- Beta 0.07, yield 3.0%, current ratio 0.64x
- Beta 0.07 vs OMI's 1.44
DBVT is the clearest fit if your priority is momentum.
- +110.4% vs OMI's -71.1%
ALKS carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
- Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
- -5.2% revenue growth vs DBVT's -100.0%
- 9.8% margin vs OMI's -39.8%
OMI is the clearest fit if your priority is value.
- Lower P/E (2.3x vs 24.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -5.2% revenue growth vs DBVT's -100.0% | |
| Value | Lower P/E (2.3x vs 24.8x) | |
| Quality / Margins | 9.8% margin vs OMI's -39.8% | |
| Stability / Safety | Beta 0.07 vs OMI's 1.44 | |
| Dividends | 3.0% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +110.4% vs OMI's -71.1% | |
| Efficiency (ROA) | 5.4% ROA vs DBVT's -89.0% |
PINC vs DBVT vs ALKS vs OMI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PINC vs DBVT vs ALKS vs OMI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKS leads in 2 of 6 categories
PINC leads 2 • OMI leads 1 • DBVT leads 1
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALKS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OMI and DBVT operate at a comparable scale, with $2.8B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to OMI's -39.8%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $0 | $1.6B | $2.8B |
| EBITDAEarnings before interest/tax | $118M | -$112M | $212M | $277M |
| Net IncomeAfter-tax profit | -$24M | -$168M | $153M | -$1.1B |
| Free Cash FlowCash after capex | $265M | -$151M | $392M | -$353M |
| Gross MarginGross profit ÷ Revenue | +72.6% | — | +65.4% | — |
| Operating MarginEBIT ÷ Revenue | -0.0% | — | +12.3% | +1.0% |
| Net MarginNet income ÷ Revenue | -2.4% | — | +9.8% | -39.8% |
| FCF MarginFCF ÷ Revenue | +26.4% | — | +25.1% | -12.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.3% | — | +28.2% | -146.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -70.0% | +91.5% | -4.1% | +4.5% |
Valuation Metrics
OMI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 24.8x trailing earnings, ALKS trades at a 81% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than PINC's 21.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.3B | $1712.35T | $5.9B | $171M |
| Enterprise ValueMkt cap + debt − cash | $2.5B | $1712.35T | $4.9B | $209M |
| Trailing P/EPrice ÷ TTM EPS | 128.45x | -0.76x | 24.76x | -0.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | — | — | 2.31x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 21.35x | — | 17.25x | 1.70x |
| Price / SalesMarket cap ÷ Revenue | 2.31x | — | 4.00x | 0.06x |
| Price / BookPrice ÷ Book value/share | 1.70x | 0.66x | 3.28x | — |
| Price / FCFMarket cap ÷ FCF | 7.33x | — | 12.28x | — |
Profitability & Efficiency
ALKS leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-21 for OMI. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to PINC's 0.18x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs OMI's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -1.6% | -130.2% | +8.8% | -21.1% |
| ROA (TTM)Return on assets | -0.8% | -89.0% | +5.4% | -44.9% |
| ROICReturn on invested capital | +0.0% | — | +18.9% | +1.8% |
| ROCEReturn on capital employed | +0.0% | -145.7% | +14.2% | +1.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 7 | 2 |
| Debt / EquityFinancial leverage | 0.18x | 0.13x | 0.04x | — |
| Net DebtTotal debt minus cash | $198M | -$172M | -$1.0B | $38M |
| Cash & Equiv.Liquid assets | $84M | $194M | $1.1B | $282M |
| Total DebtShort + long-term debt | $282M | $22M | $70M | $320M |
| Interest CoverageEBIT ÷ Interest expense | 1.13x | -189.82x | 32.30x | -0.12x |
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, DBVT leads with a +110.4% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs OMI's -49.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | — | +4.9% | +25.3% | -3.4% |
| 1-Year ReturnPast 12 months | +24.0% | +110.4% | +16.5% | -71.1% |
| 3-Year ReturnCumulative with dividends | +14.8% | +19.7% | +14.5% | -87.4% |
| 5-Year ReturnCumulative with dividends | -9.2% | -69.1% | +60.9% | -93.5% |
| 10-Year ReturnCumulative with dividends | -4.6% | -87.0% | -11.0% | -86.2% |
| CAGR (3Y)Annualised 3-year return | +4.7% | +6.2% | +4.6% | -49.9% |
Risk & Volatility
PINC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PINC is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 1.26x | 1.00x | 1.45x |
| 52-Week HighHighest price in past year | $28.79 | $26.18 | $36.60 | $9.55 |
| 52-Week LowLowest price in past year | $20.62 | $7.53 | $25.17 | $1.84 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +76.3% | +96.7% | +23.5% |
| RSI (14)Momentum oscillator 0–100 | 65.0 | 48.1 | 60.2 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 0 | 252K | 2.3M | 690K |
Analyst Outlook
PINC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: PINC as "Hold", DBVT as "Buy", ALKS as "Buy", OMI as "Hold". Consensus price targets imply 596.4% upside for OMI (target: $16) vs 17.3% for PINC (target: $33). PINC is the only dividend payer here at 2.98% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $33.15 | $46.33 | $46.00 | $15.60 |
| # AnalystsCovering analysts | 31 | 15 | 28 | 10 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.84 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +17.1% | 0.0% | +0.5% | 0.0% |
ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PINC leads in 2 (Risk & Volatility, Analyst Outlook).
PINC vs DBVT vs ALKS vs OMI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PINC or DBVT or ALKS or OMI a better buy right now?
For growth investors, Alkermes plc (ALKS) is the stronger pick with -5.
2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PINC or DBVT or ALKS or OMI?
On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.
8x versus Premier, Inc. at 128. 5x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PINC or DBVT or ALKS or OMI?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.
9%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: PINC returned -4. 6% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PINC or DBVT or ALKS or OMI?
By beta (market sensitivity over 5 years), Premier, Inc.
(PINC) is the lower-risk stock at 0. 21β versus Owens & Minor, Inc. 's 1. 45β — meaning OMI is approximately 592% more volatile than PINC relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 18% for Premier, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PINC or DBVT or ALKS or OMI?
By revenue growth (latest reported year), Alkermes plc (ALKS) is pulling ahead at -5.
2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Alkermes plc grew EPS -34. 1% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PINC or DBVT or ALKS or OMI?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PINC or DBVT or ALKS or OMI more undervalued right now?
On forward earnings alone, Owens & Minor, Inc.
(OMI) trades at 2. 3x forward P/E versus 20. 8x for Premier, Inc. — 18. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 596. 4% to $15. 60.
08Which pays a better dividend — PINC or DBVT or ALKS or OMI?
In this comparison, PINC (3.
0% yield) pays a dividend. DBVT, ALKS, OMI do not pay a meaningful dividend and should not be held primarily for income.
09Is PINC or DBVT or ALKS or OMI better for a retirement portfolio?
For long-horizon retirement investors, Premier, Inc.
(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 0% yield). Both have compounded well over 10 years (PINC: -4. 6%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PINC and DBVT and ALKS and OMI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
PINC pays a dividend while DBVT, ALKS, OMI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.